Marrs Anna 4

What Happened
Anna Marrs, a director at DocuSign (DOCU), had 729 restricted stock units (RSUs) converted to shares (reported as an exercise/conversion of a derivative at $0.00) on 2026-02-28. The filing also reports an open-market sale of 365 shares on 2026-03-03 at $45.02 per share for total proceeds of $16,432. The transactions show a net sale of 365 shares; the RSU conversion and the zero-price derivative disposition are reported separately in the Form 4.

Key Details

• Dates and prices:
  • 2026-02-28: 729 RSUs converted to 729 shares (reported as M, acquired at $0.00).
  • 2026-02-28: 729 shares reported disposed as a derivative at $0.00 (same date).
  • 2026-03-03: 365 shares sold on the open market at $45.02, proceeds $16,432.
• Net effect: 365-share reduction in holdings (729 conversion netted by a same-day derivative disposition; then 365 shares sold). The Form 4 does not state the total number of shares owned after these transactions.
• Notable footnotes:
  • F1: The sale was effected pursuant to a Rule 10b5-1 trading plan.
  • F2–F4: The transactions involve RSUs (each RSU = one share) with a vesting schedule beginning May 29, 2025 and vesting quarterly over one year; RSUs do not expire.
• Filing timeliness: The form was filed 2026-03-03 covering transactions dated 2026-02-28 and 2026-03-03. The filing does not indicate it was late.

Context

• These entries reflect RSU conversion and a subsequent open-market sale under a prearranged 10b5-1 plan. The zero-dollar derivative entries reflect conversion/handling of RSUs as reported; the Form 4 treats those as exercise/conversion and a derivative disposition. The sale is relatively small ($16.4k) and routine; factual reporting here does not indicate the insider’s motivations.